The Global Research on Antimicrobial Resistance (GRAM) Findings Launch
February 4, 2022
4 years, 471 million individual records or isolates, and 7585 study-location-years' worth of data have led to the most comprehensive analysis of the burden of AMR ever undertaken. For the first time, evidence shows that AMR is a leading cause of death globally, with new estimates highlighting the scale of the global health threat.
The GRAM report was published by The Lancet in January, 2022 and we presented the findings, including:
Exploring these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations
Celebrating the global collaboration and 100’s of data partnerships that made this study possible
Considering how data can be harnessed to support governments, health systems and civil society to act and reduce the human-cost of AMR
Identifying immediate actions that can help countries around the world protect their health systems against the threat of AMR
Professor Chris Murray, Director of the Institute for Health Metrics and Evaluation
Dame Sally Davies, UK Special Envoy on AMR
Dr Hanan Balkhy, Assistant Director General for Antimicrobial Resistance, World Health Organization
Dr Richard Horton, Editor-in-Chief of The Lancet
The GRAM project is a collaboration led by the Institute for Health Metrics and Evaluation and the University of Oxford and was funded by the Fleming Fund, the Bill & Melinda Gates Foundation and Wellcome Trust.
Gisela Robles Aguilar, Lucien Swetschinski, Mohsen Naghavi, Christopher J.L. Murray, Simon Hay, Nicole Weaver, Kevin Ikuta, Tomislav Mestrovic, Authia Gray, Eunice Chung, Eve Wool, Chieh Han, Aaron Huang, Anna Hayoon, Daniel Araki, Aleksandr Aravkin, Xiaochen Dai, Mohammed Hassen, Hmwe Hmwe Kyu, Stephen Lim, Ali Mokdad, Hasan Nassereldine, Dereje Yohannis Yada